Abstract
The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.
| Original language | English |
|---|---|
| Pages (from-to) | 426-428 |
| Number of pages | 3 |
| Journal | Annals of laboratory medicine |
| Volume | 32 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2012 Nov |
All Science Journal Classification (ASJC) codes
- Clinical Biochemistry
- Biochemistry, medical
Fingerprint Dive into the research topics of 'Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea'. Together they form a unique fingerprint.
Cite this
Jung, S. I., Shin, J. H., Choi, H. J., Ju, M. Y., Kim, S. H., Lee, W. G., Park, Y. J., & Lee, K. (2012). Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea. Annals of laboratory medicine, 32(6), 426-428. https://doi.org/10.3343/alm.2012.32.6.426